{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:02:00Z","timestamp":1761948120539,"version":"build-2065373602"},"reference-count":69,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1053\/j.seminhematol.2007.01.004","type":"journal-article","created":{"date-parts":[[2007,4,12]],"date-time":"2007-04-12T07:13:10Z","timestamp":1176361990000},"page":"98-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Sex Hormones and Thrombosis"],"prefix":"10.1053","volume":"44","author":[{"given":"Henry G.","family":"Watson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2007.01.004_bib1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1365-2141.2005.05715.x","article-title":"Screening for thrombophilia in high-risk situations: A meta-analysis and cost-effectiveness analysis","volume":"131","author":"Wu","year":"2005","journal-title":"Br J Haematol"},{"year":"2002","series-title":"World Contraceptive Use 2001","key":"10.1053\/j.seminhematol.2007.01.004_bib2"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib3","first-page":"191","article-title":"Use of HRT and the subsequent risk of cancer","volume":"4","author":"Beral","year":"1999","journal-title":"J Epidemiol Biostat"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib4","first-page":"1146","article-title":"Pulmonary embolism","volume":"2","author":"Jordan","year":"1961","journal-title":"Br Med J"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0140-6736(63)91117-6","article-title":"Coronary thrombosis and Conovide","volume":"1","author":"Boyce","year":"1963","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.2.5313.1191-a","article-title":"Parietal lesions and Enavid","volume":"2","author":"Lorentz","year":"1962","journal-title":"Br Med J"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib7","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0140-6736(96)07113-9","article-title":"Risk of venous thromboembolism in users of hormone replacement therapy","volume":"348","author":"Daly","year":"1996","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib8","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(96)07308-4","article-title":"Prospective study of exogenous hormones and risk of pulmonary embolism in women","volume":"348","author":"Grodstein","year":"1996","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women\u2019s Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib10","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S0140-6736(77)90888-1","article-title":"Haemostatic, lipid, and blood-pressure profiles of women on oral contraceptives containing 50 microgram or 30 microgram oestrogen","volume":"2","author":"Meade","year":"1977","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib11","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1055\/s-0038-1650651","article-title":"Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives","volume":"76","author":"Quehenberger","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib12","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1055\/s-0038-1649849","article-title":"Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: Absence of dose-dependent effect on PAI-1 activity","volume":"74","author":"Scarabin","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib13","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/j.1471-0528.1991.tb15364.x","article-title":"A multicentre study of coagulation and haemostatic variables during oral contraception: variations with four formulations","volume":"98","year":"1991","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1365-2141.1997.192707.x","article-title":"Oral contraceptives and venous thrombosis: Different sensitivities to activated protein C in women using second- and third-generation oral contraceptives","volume":"97","author":"Rosing","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib15","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/S0140-6736(99)06092-4","article-title":"Low-dose oral contraceptives and acquired resistance to activated protein C: A randomised cross-over study","volume":"354","author":"Rosing","year":"1999","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-0037-1613960","article-title":"A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways","volume":"84","author":"Tans","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib17","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/gye.16.4.335.346","article-title":"The effects of postmenopausal hormone replacement therapy on hemostatic variables: A meta-analysis of 46 studies","volume":"16","author":"Acs","year":"2002","journal-title":"Gynecol Endocrinol"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib18","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1055\/s-0037-1613958","article-title":"Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: A cross-over study","volume":"84","author":"Middeldorp","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archinte.160.1.49","article-title":"Higher risk of venous thrombosis during early use of oral contraceptives in women with inherited clotting defects","volume":"160","author":"Bloemenkamp","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0140-6736(99)01257-X","article-title":"Venous thromboembolism among new users of different oral contraceptives","volume":"354","author":"Herings","year":"1999","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib21","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0140-6736(95)91929-5","article-title":"Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen","volume":"346","author":"Bloemenkamp","year":"1995","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/oxfordjournals.aje.a115799","article-title":"Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease","volume":"133","author":"Gerstman","year":"1991","journal-title":"Am J Epidemiol"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib23","first-page":"267","article-title":"Oral contraception and thrombo-embolic disease","volume":"13","year":"1967","journal-title":"J R Coll Gen Pract"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib24","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1001\/archinte.164.18.1965","article-title":"Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: A clinical review","volume":"164","author":"Gomes","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2796.1995.tb00896.x","article-title":"Oral contraceptives and venous thromboembolism: A quantitative discussion of the uncertainties","volume":"238","author":"Koster","year":"1995","journal-title":"J Intern Med"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib26","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/ije\/19.4.931","article-title":"Oral contraceptive oestrogen and progestin potencies and the incidence of deep venous thromboembolism","volume":"19","author":"Gerstman","year":"1990","journal-title":"Int J Epidemiol"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib27","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archinte.159.1.65","article-title":"Risk of venous thrombosis with use of current low-dose oral contraceptives is not explained by diagnostic suspicion and referral bias","volume":"159","author":"Bloemenkamp","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0010-7824(01)00307-9","article-title":"Oral contraceptives and venous thromboembolism: A five-year national case-control study","volume":"65","author":"Lidegaard","year":"2002","journal-title":"Contraception"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib29","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0140-6736(95)91928-7","article-title":"Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components","volume":"346","author":"Jick","year":"1995","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib30","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0140-6736(95)91927-9","article-title":"Effect of different progestogens in low oestrogen oral contraceptives on venous thromboembolic disease","volume":"346","year":"1995","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0010-7824(01)00234-7","article-title":"Risk of venous thromboembolism from oral contraceptives containing gestodene and desogestrel versus levonorgestrel: A meta-analysis and formal sensitivity analysis","volume":"64","author":"Hennessy","year":"2001","journal-title":"Contraception"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/bmj.323.7305.131","article-title":"Third generation oral contraceptives and risk of venous thrombosis: Meta-analysis","volume":"323","author":"Kemmeren","year":"2001","journal-title":"BMJ"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib33","first-page":"1","article-title":"Venous thromboembolism and hormonal contraception","volume":"40","year":"2004","journal-title":"Guideline"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib34","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.contraception.2006.05.071","article-title":"Cerebral venous sinus thrombosis in users of four hormonal contraceptives: Levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch","volume":"74","author":"Jick","year":"2006","journal-title":"Contraception"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib35","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(01)06522-9","article-title":"Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives","volume":"358","author":"Vasilakis-Scaramozza","year":"2001","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib36","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/pds.896","article-title":"Venous thromboembolism associated with cyproterone acetate in combination with ethinyloestradiol (Dianette): Observational studies using the UK General Practice Research Database","volume":"13","author":"Seaman","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib37","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S1701-2163(16)30342-5","article-title":"Cyproterone acetate with ethinylestradiol as a risk factor for venous thromboembolism: An epidemiological evaluation","volume":"25","author":"Spitzer","year":"2003","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib38","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1365-2125.2005.02373.x","article-title":"Deep vein thrombosis and pulmonary embolism reported in the Prescription Event Monitoring Study of Yasmin","volume":"60","author":"Pearce","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib39","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.2165\/00002018-200427130-00003","article-title":"Safety of a new oral contraceptive containing drospirenone","volume":"27","author":"Heinemann","year":"2004","journal-title":"Drug Saf"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib40","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.contraception.2006.01.001","article-title":"Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 \u03bcg of ethinyl estradiol","volume":"73","author":"Jick","year":"2006","journal-title":"Contraception"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib41","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/S0140-6736(99)04394-9","article-title":"Risk of idiopathic venous thromboembolism in users of progestagens alone","volume":"354","author":"Vasilakis","year":"1999","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib42","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/S0140-6736(99)03132-3","article-title":"Risk of cardiovascular diseases associated with oral progestagen preparations with therapeutic indications","volume":"354","author":"Poulter","year":"1999","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib43","first-page":"1513","article-title":"A multinational case-control study of cardiovascular disease and steroid hormone contraceptives","volume":"48","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib44","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7326\/0003-4819-132-9-200005020-00002","article-title":"Postmenopausal hormone therapy increases risk for venous thromboembolic disease","volume":"132","author":"Grady","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib45","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0140-6736(02)11032-4","article-title":"Evidence from randomised trials on the long-term effects of hormone replacement therapy","volume":"360","author":"Beral","year":"2002","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib46","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0140-6736(96)07114-0","article-title":"Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens","volume":"348","author":"Jick","year":"1996","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib47","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/bmj.314.7083.796","article-title":"Hormone replacement therapy and risk of venous thromboembolism: Population based case-control study","volume":"314","author":"Perez","year":"1997","journal-title":"BMJ"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib48","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/oxfordjournals.aje.a009461","article-title":"Hormone replacement therapy and the risk of hospitalization for venous thromboembolism: A population-based study in southern Europe","volume":"147","author":"Varas-Lorenzo","year":"1998","journal-title":"Am J Epidemiol"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib49","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1538-7836.2005.01268.x","article-title":"Does the type of hormone replacement therapy influence the risk of deep vein thrombosis?","volume":"3","author":"Douketis","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib50","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1001\/jama.292.13.1581","article-title":"Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis","volume":"292","author":"Smith","year":"2004","journal-title":"JAMA"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib51","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(03)14066-4","article-title":"Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk","volume":"362","author":"Scarabin","year":"2003","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib52","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1161\/CIRCULATIONAHA.105.565556","article-title":"Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: Impact of the route of estrogen administration","volume":"112","author":"Straczek","year":"2005","journal-title":"Circulation"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib53","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(95)91926-0","article-title":"Venous thromboembolic disease and combined oral contraceptives: Results of international multicentre case-control study","volume":"346","year":"1995","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib54","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/humrep\/15.4.817","article-title":"Recurrent use of newer oral contraceptives and the risk of venous thromboembolism","volume":"15","author":"Suissa","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib55","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1055\/s-0037-1613379","article-title":"Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use","volume":"89","author":"Abdollahi","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib56","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1001\/jama.292.13.1573","article-title":"Estrogen plus progestin and risk of venous thrombosis","volume":"292","author":"Cushman","year":"2004","journal-title":"JAMA"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib57","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0140-6736(96)07496-X","article-title":"Population-based study of risk of venous thromboembolism associated with various oral contraceptives","volume":"349","author":"Farmer","year":"1997","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib58","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1046\/j.1365-2125.2000.00198.x","article-title":"A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives","volume":"49","author":"Farmer","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib59","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1055\/s-0037-1614156","article-title":"Increased risk of recurrent venous thromboembolism during hormone replacement therapy\u2014Results of the randomized, double-blind, placebo-controlled Estrogen in Venous Thromboembolism Trial (EVTET)","volume":"84","author":"Hoibraaten","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib60","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/bmj.3.5715.123","article-title":"Postoperative thromboembolism and the use of oral contraceptives","volume":"3","author":"Vessey","year":"1970","journal-title":"Br Med J"},{"first-page":"1","year":"2004","series-title":"Hormone Replacement Therapy and Venous Thromboembolism","key":"10.1053\/j.seminhematol.2007.01.004_bib61"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib62","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0140-6736(03)14111-6","article-title":"Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: Prospective cohort study","volume":"362","author":"Baglin","year":"2003","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib63","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1182\/blood.V92.7.2353","article-title":"Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: A study of 150 families","volume":"92","author":"Martinelli","year":"1998","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib64","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1055\/s-0037-1614442","article-title":"Incidence of venous thromboembolism in families with inherited thrombophilia","volume":"81","author":"Simioni","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib65","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(94)90286-0","article-title":"Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation","volume":"344","author":"Vandenbroucke","year":"1994","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib66","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1182\/blood.V85.6.1504.bloodjournal8561504","article-title":"High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)","volume":"85","author":"Rosendaal","year":"1995","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib67","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/01.ATV.19.3.700","article-title":"Interaction between the G20210A mutation of the prothrombin gene and oral contraceptive use in deep vein thrombosis","volume":"19","author":"Martinelli","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib68","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1160\/TH04-11-0759","article-title":"Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: A systematic review","volume":"94","author":"Wu","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2007.01.004_bib69","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1055\/s-0037-1613857","article-title":"Thrombotic variables and risk of idiopathic venous thromboembolism in women aged 45-64 years","volume":"83","author":"Lowe","year":"2000","journal-title":"Thromb Haemost"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196307000054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196307000054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:19:02Z","timestamp":1758521942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196307000054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":69,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S0037196307000054"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2007.01.004","relation":{},"ISSN":["0037-1963"],"issn-type":[{"type":"print","value":"0037-1963"}],"subject":[],"published":{"date-parts":[[2007,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sex Hormones and Thrombosis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2007.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}